{"schema_version":"1","generated_at":"2026-11-04T08:19:28.084Z","data_as_of":null,"url":"https://www.findmykol.com/kol/leslie-mcallister","json_url":"https://www.findmykol.com/kol/leslie-mcallister/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"leslie-mcallister","name":"Leslie McAllister","credential":"MD","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"institution":"Oregon Health & Science University","institution_url":"https://www.findmykol.com/institution/oregon-health-science-university","city":"Portland","state":"OR","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1407848831","openalex":"A5108546966"},"summary":"Leslie McAllister is a Neurology physician affiliated with Oregon Health & Science University. OpenAlex indexes 9 publications with 849 citations (h-index 7); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"works_count":9,"cited_by_count":849,"h_index":7,"latest_activity_year":2003,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00003292","title":"S9624 Ifosfamide in Treating Patients With Meningeal Tumors","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"SWOG Cancer Research Network","source_url":"https://clinicaltrials.gov/study/NCT00003292","trial_url":"https://www.findmykol.com/trial/NCT00003292"}],"source":"trials"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Hormonal (systemic)","share_pct":39.5,"classes_total":1,"classes":[{"class":"l-Thyroxine","setting":"prescribed","share_pct":39.5,"drugs":[{"name":"Levothyroxine Sodium","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":31.6,"classes_total":1,"classes":[{"class":"Beta blocker","setting":"prescribed","share_pct":31.6,"drugs":[{"name":"Atenolol","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":28.9,"classes_total":1,"classes":[{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":28.9,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":9,"shown":5,"withheld":4,"matched_by":"OpenAlex author record","recent":[{"title":"Anaplastic Oligodendrogliomas: Prognostic Factors for Tumor Recurrence and Survival","year":2003,"journal":"Oncology","source_url":"https://doi.org/10.1159/000074479","status":"verified"},{"title":"Primary central nervous system lymphoma: A review","year":2002,"journal":"Current Neurology and Neuroscience Reports","source_url":"https://doi.org/10.1007/s11910-002-0079-1","status":"verified"},{"title":"Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors","year":2000,"journal":"Cancer","source_url":"https://doi.org/10.1002/(sici)1097-0142(20000201)88:3<637::aid-cncr22>3.0.co;2-y","status":"verified"},{"title":"Cognitive Outcomes and Long-term Follow-up Results after Enhanced Chemotherapy Delivery for Primary Central Nervous System Lymphoma","year":2000,"journal":"Neurosurgery","source_url":"https://doi.org/10.1093/neurosurgery/46.1.51","status":"verified"},{"title":"Unusual cervical spinal cord toxicity associated with intra-arterial carboplatin, intra-arterial or intravenous etoposide phosphate, and intravenous cyclophosphamide in conjunction with osmotic blood brain-barrier disruption in the vertebral artery.","year":2000,"journal":"PubMed","status":"verified"}],"source":"works"},"contact":{"address_1":"1040 NW 22ND AVE","address_2":"SUITE 420","city":"Portland","state":"OR","zip":"972103057","phone":"503-488-2424","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1407848831","source":"identity"},"similar":[{"name":"Brian Druker","slug":"brian-druker","institution":"Oregon Health & Science University","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/brian-druker","json_url":"https://www.findmykol.com/kol/brian-druker/profile.json"},{"name":"Kevin Winthrop","slug":"kevin-winthrop","institution":"Oregon Health & Science University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/kevin-winthrop","json_url":"https://www.findmykol.com/kol/kevin-winthrop/profile.json"},{"name":"Richard Maziarz","slug":"richard-maziarz","institution":"Oregon Health & Science University","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/richard-maziarz","json_url":"https://www.findmykol.com/kol/richard-maziarz/profile.json"},{"name":"Wayne Clark","slug":"wayne-clark","institution":"Oregon Health & Science University","specialty":"Neurology","url":"https://www.findmykol.com/kol/wayne-clark","json_url":"https://www.findmykol.com/kol/wayne-clark/profile.json"},{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":4}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2009-05-14","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}